Endocrine Testing Product Market
Global endocrine testing product market is estimated to be valued at USD 13.69 Bn in 2024, exhibiting a CAGR of 9.2% during the forecast period (2024-2031). Endocrine testing product refers to in vitro diagnostics that are used to test the functionality of the endocrine system. Endocrine system is a regulatory system composed of glands that secrete hormones directly into the circulatory system to regulate distant target organs. Endocrine testing products help physicians monitor hormone levels and screen for endocrine disorders. Some common endocrine tests include thyroid function tests, testosterone testing, estrogen testing, prolactin testing, cortisol testing, and insulin testing. Rising prevalence of endocrine-related diseases such as diabetes, thyroid disorders, and hormonal imbalance disorders can boost demand for endocrine testing worldwide. Advancements in diagnostic technologies have enabled the development of sensitive bioassays and automated solutions for high-throughput endocrine testing in clinical laboratories.
Market Dynamics
Global endocrine testing product market growth is driven by growing geriatric population who are more prone to developing endocrine disorders, increasing awareness and screening of endocrine conditions, and expanding applications of endocrine function tests in disease diagnosis and management. However, lengthy and complex regulatory processes for new product approvals and reluctance to change existing testing procedures can hamper the market growth. The market witness lucrative opportunities from the development of advanced immunoassay platforms with improved accuracy, high test volumes per run, and integrated informatics. This allows for the testing of multiple hormones simultaneously using small sample volumes.
Key Features of the Study
- This report provides in-depth analysis of the global endocrine testing product market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global endocrine testing product market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc, Danaher, Immunodiagnostic Systems, and Fujirebio, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global endocrine testing product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global endocrine testing product market
Market Segmentation
Market Segmentation
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
